Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) – Equities researchers at Roth Capital issued their Q1 2025 earnings per share (EPS) estimates for shares of Aspen Aerogels in a research note issued on Thursday, October 17th. Roth Capital analyst C. Moore forecasts that the construction company will post earnings per share of $0.02 for the quarter. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.05 EPS, Q3 2025 earnings at $0.18 EPS, FY2025 earnings at $0.50 EPS and FY2026 earnings at $1.00 EPS.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. During the same quarter last year, the business posted ($0.22) earnings per share. The company’s revenue for the quarter was up 144.4% compared to the same quarter last year.
Check Out Our Latest Analysis on ASPN
Aspen Aerogels Stock Down 3.7 %
Shares of ASPN stock opened at $21.60 on Friday. The company’s fifty day simple moving average is $26.00 and its two-hundred day simple moving average is $24.40. Aspen Aerogels has a 52 week low of $6.62 and a 52 week high of $33.15. The stock has a market cap of $1.65 billion, a P/E ratio of -49.09 and a beta of 2.16. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23.
Institutional Trading of Aspen Aerogels
Several institutional investors and hedge funds have recently modified their holdings of the stock. GSA Capital Partners LLP bought a new position in shares of Aspen Aerogels during the first quarter valued at approximately $1,181,000. Oppenheimer & Co. Inc. purchased a new position in shares of Aspen Aerogels in the 1st quarter valued at $388,000. Comerica Bank bought a new position in shares of Aspen Aerogels in the 1st quarter worth $1,992,000. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock worth $1,922,000 after purchasing an additional 32,243 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after purchasing an additional 175,906 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.
Insider Activity at Aspen Aerogels
In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
See Also
- Five stocks we like better than Aspen Aerogels
- What Are Dividend Contenders? Investing in Dividend Contenders
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Market Sectors: What Are They and How Many Are There?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.